Bo Pang

802 total citations
22 papers, 641 citations indexed

About

Bo Pang is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Bo Pang has authored 22 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Bo Pang's work include Glioma Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and Epigenetics and DNA Methylation (4 papers). Bo Pang is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (5 papers) and Epigenetics and DNA Methylation (4 papers). Bo Pang collaborates with scholars based in China, Japan and United States. Bo Pang's co-authors include Qi Pang, Taihong Gao, Shangchen Xu, Tao Xin, Rui Zhang, Yibing Fu, Hua Guo, Rui Zhang, Bin Feng and Shicheng Sun and has published in prestigious journals such as RSC Advances, Cell Death and Disease and Human Pathology.

In The Last Decade

Bo Pang

22 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Pang China 15 451 256 93 88 78 22 641
Audrey Griveau France 14 428 0.9× 157 0.6× 117 1.3× 49 0.6× 50 0.6× 25 731
Yang Kong China 13 516 1.1× 321 1.3× 105 1.1× 57 0.6× 234 3.0× 37 804
Paolo G. Montaldo Italy 14 447 1.0× 163 0.6× 88 0.9× 44 0.5× 39 0.5× 20 700
Pamela Swain United States 7 587 1.3× 304 1.2× 88 0.9× 79 0.9× 36 0.5× 13 888
Meiqing Lou China 16 352 0.8× 142 0.6× 114 1.2× 94 1.1× 82 1.1× 40 705
Shabierjiang Jiapaer Japan 9 270 0.6× 154 0.6× 66 0.7× 160 1.8× 41 0.5× 12 456
Mohammad Hasan Soheilifar Iran 13 243 0.5× 139 0.5× 117 1.3× 31 0.4× 42 0.5× 35 481
Hongquan Yu China 16 732 1.6× 454 1.8× 168 1.8× 138 1.6× 77 1.0× 36 1.0k
Ilya V. Pyko Japan 9 388 0.9× 148 0.6× 107 1.2× 174 2.0× 128 1.6× 9 686

Countries citing papers authored by Bo Pang

Since Specialization
Citations

This map shows the geographic impact of Bo Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Pang more than expected).

Fields of papers citing papers by Bo Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Pang. The network helps show where Bo Pang may publish in the future.

Co-authorship network of co-authors of Bo Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Pang. A scholar is included among the top collaborators of Bo Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Pang. Bo Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shicheng, Taihong Gao, Bo Pang, et al.. (2022). RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m6A-dependent manner. Cell Death and Disease. 13(1). 73–73. 82 indexed citations
2.
Yang, Yihang, Qing Yang, Bo Pang, et al.. (2021). NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma. BMC Cancer. 21(1). 1181–1181. 24 indexed citations
3.
Yang, Yihang, Bo Pang, Zihao Liu, et al.. (2019). 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Induces the Apoptosis of Dopaminergic Neurons via Oxidative Stress and Neuroinflammation. Oxidative Medicine and Cellular Longevity. 2019. 1–12. 5 indexed citations
4.
Liu, Bin, Bo Pang, Pengbo Guo, et al.. (2017). Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma. Journal of Neuro-Oncology. 132(3). 409–417. 23 indexed citations
5.
Liu, Bin, Bo Pang, Qirui Wang, et al.. (2017). EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas. Human Pathology. 66. 101–107. 17 indexed citations
6.
Zheng, Xiangrong, Bo Pang, Taihong Gao, et al.. (2017). Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis. International Journal of Biological Sciences. 13(2). 245–253. 56 indexed citations
8.
Pang, Bo, Xiangrong Zheng, Taihong Gao, et al.. (2016). EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling. Oncotarget. 7(29). 45134–45143. 46 indexed citations
9.
Zhang, Rui, Bo Pang, Tao Xin, et al.. (2015). Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma. Molecular Neurobiology. 53(3). 1452–1460. 65 indexed citations
10.
Liu, Bin, Bo Pang, Yoshiki Arakawa, et al.. (2015). High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme. Pathology - Research and Practice. 211(8). 596–600. 11 indexed citations
11.
Wang, Zhiqi, Kai Liu, Xiaochen Li, et al.. (2015). A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy. Journal of Nanobiotechnology. 13(1). 63–63. 49 indexed citations
12.
Liu, Ping, Liang Sun, Hui Cheng Chen, et al.. (2015). Lentiviral-mediated multiple gene transfer to chondrocytes promotes chondrocyte differentiation and bone formation in rabbit bone marrow-derived mesenchymal stem cells. Oncology Reports. 34(5). 2618–2626. 4 indexed citations
13.
Liu, Bin, Bo Pang, Haitao Fan, et al.. (2014). Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas. Human Pathology. 45(8). 1752–1758. 30 indexed citations
14.
Fu, Yibing, Jing Chen, Bo Pang, et al.. (2014). EZH2-Induced H3K27me3 is Associated with Epigenetic Repression of the ARHI Tumor-Suppressor Gene in Ovarian Cancer. Cell Biochemistry and Biophysics. 71(1). 105–112. 32 indexed citations
15.
Chen, Xin, Weiyuan Ma, Shangchen Xu, et al.. (2014). The overexpression of Epithelial cell adhesion molecule (EpCAM) in glioma. Journal of Neuro-Oncology. 119(1). 39–47. 23 indexed citations
16.
Liu, Wei, Bo Pang, Ming Lü, et al.. (2012). The rs42524 COL1A2 polymorphism is associated with primary intracerebral hemorrhage in a Chinese population. Journal of Clinical Neuroscience. 19(12). 1711–1714. 6 indexed citations
17.
Pang, Bo, Haitao Fan, Bin Liu, et al.. (2011). HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis. Journal of Neuro-Oncology. 106(3). 543–549. 32 indexed citations
18.
Pang, Bo, Tao Xin, Xuben Hou, et al.. (2011). Increased Signal Transducer and Activator of Transcription 3 (STAT3) and Decreased Cyclin D1 in Recurrent Astrocytic Tumours Compared with Paired Primary Astrocytic Tumours. Journal of International Medical Research. 39(6). 2103–2109. 4 indexed citations
19.
Liu, Wei, Yibing Fu, Shangchen Xu, et al.. (2010). c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme. Journal of Clinical Neuroscience. 18(1). 119–121. 38 indexed citations
20.
Liu, Weiwei, Hui‐Tao Fan, Bin Liu, et al.. (2010). Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas. Neuro-Oncology. 12(8). 799–803. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026